Michel Attal, MD, PhD

Institut Universitaire du Cancer de Toulouse-Oncopole
Toulouse France Papers:
3171 Deciphering the Chronology of Copy Number Alterations in Multiple Myeloma (MM): What Comes First?
3245 Integrated Analysis of Randomized Controlled Trials Evaluating Bortezomib + Lenalidomide + Dexamethasone or Bortezomib + Thalidomide + Dexamethasone Induction in Transplant-Eligible Newly Diagnosed Multiple Myeloma